Vancomycin has remained a useful antimicrobial agent over three decades in part because resistance has been slow to emerge. However, several reports of the isolation of Enterococcus faecium and Enterococcus faecalis resistant to high concentrations of vancomycin have recently appeared (4, 5, 8, 9 ). Here we report characterization of a vancomycin-resistant isolate of E. faecium previously reported by Uttley et al. (9) .
Bacterial strains and antibiotic resistance determinations. Bacterial strains are described in Table 1 . MICs of antibiotvancomycin per ml. One vancomycin-susceptible isolate, E. faecium 180-1, was retained for further study.
E. faecium 180 was capable of transferring vancomycin resistance by conjugation. Bacterial conjugation was performed on membrane filters or in liquid medium as previously described (2, 7) . Transconjugants were selected on Trypticase soy agar containing 20 pLg of vancomycin per ml and either fusidic acid (50 ,ug/ml) or streptomycin (1,000 pg/ml). Frequencies of transfer were -8.1 x 10-5 vancomycin-resistant transconjugants per donor when the cured This study resistance to vancomycin and fusidic acid ics were determined on Mueller-Hinton agar by using an inoculum of -104 bacteria per agar surface spot. Vancomycin, daptomycin, and tobramycin were from Eli Lilly & Co., Indianapolis, Ind. Erythromycin, chloramphenicol, ampicillin, fusidic acid, and streptomycin were purchased from Sigma Chemical Co., St. Louis, Mo. Teicoplanin was from Gruppo Lepetit, Milan, Italy; and amikacin was from Bristol-Myers, Syracuse, N.Y.
Transfer and curing of vancomycin resistance. E. faecium 180 was chosen as a representative resistant strain from the group of 55 resistant enterococci previously reported (9) . This strain was cured of its resistance to vancomycin by growth at 43°C or by growth in novobiocin (2 ,ug/ml) or acridine orange (40 jig/ml) at frequencies of 1, 1, and 0.4%, respectively. Of 20 vancomycin-susceptible cured isolates tested, all remained resistant to all markers ( (4, 5) . Two E. faecium strains studied by this group carry distinct but related plasmids, one of which also encodes macrolide and streptomycin resistance. Transferable vancomycin resistance in one strain of E. faecalis has also been reported (8) .
Inducibility of vancomycin resistance. Cultures were grown overnight in brain heart infusion broth at 37TC with or without inducing concentrations of vancomycin or teicoplanin, and they were subcultured by being diluted 1:100 in 20 ml of brain heart infusion broth with the same concentration of antibiotic. These cultures were grown at 37°C with shaking until the A600 reached -0.1, at which time vancomycin or teicoplanin was added. When 20 j.g of vancomycin per ml was added to growing cultures of the vancomycin-resistant strain, E. faecium 180, growth virtually ceased after about one generation (Fig. 1A) . Growth resumed after a lag of several hours. In contrast, when cultures grown in the presence of low concentrations of vancomycin were similarly subjected to the addition of vancomycin to 20 jig/ml, growth continued (Fig. 1A) , suggesting that expression of resistance to vancomycin requires induction. Prior growth in concentrations as low as 0.2 jig of vancomycin per ml was effective in suppressing a lag on further vancomycin addition (data not shown). The vancomycin-susceptible strain E. faecium 180-1 was inhibited by vancomycin even when grown in the presence of subinhibitory concentrations of vancomycin (Fig. 1B) . Cultures exposed to low concentrations of vancomycin also showed resistance to teicoplanin ( Fig. 2A) . Teicoplanin was also an effective inducer of glycopeptide resistance: concentrations as low as 0.01 jig/ml induced resistance to vancomycin, as demonstrated by absence of a lag when vancomycin was added to 20 jig/ml (Fig.   2B ). Similar inducible resistance was observed in the vancomycin-resistant E. faecalis transconjugant 29212R, but not in its vancomycin-susceptible parent E. faecalis 29212 (data not shown). Shlaes et al. (8) have shown similar inducibility of vancomycin resistance in a resistant isolate of E. faecalis, although in their experiments, induction by teicoplanin was less pronounced than induction by other glycopeptides. Inducible resistance has also been shown for two vancomycin-resistant E. faecium strains (4). nducible vancomycin-resistant cell wall biosynthesis. Incorporation of radiolabeled L-alanine into peptidoglycan of E. faecium was measured as described previously (6) , except that 50 jig of L-lysine per ml was used in place of 2,6-diaminopimelic acid, and 100 jig of tetracycline per ml in place of chloramphenicol was used to ensure complete inhibition of protein synthesis. Cells grown to mid-log phase in wall-thickening medium (CGPY broth; 6) in the presence or absence of vancomycin were harvested and suspended in cell wall synthesis medium containing 0. ible resistance of cell wall biosynthesis to vancomycin has also been reported for a vancomycin-resistant strain of E. faecalis (8) .
Membrane proteins in vancomycin-resistant strains. Membranes were prepared from cells grown to late stationary phase in brain heart infusion broth with the specified concentrations of vancomycin (Fig. 3) . Washed cells were incubated in 10 mM sodium phosphate buffer (pH 7.0) with 100 ,ug of lysozyme (Sigma) per ml, 4 mM EDTA, and 1 mM phenylmethylsulfonyl fluoride (Sigma) for 1.5 h at 35°C and were then disrupted by sonication. Unbroken cells were removed by low-speed centrifugation, and membranes were collected by ultracentrifugation at 135,000 x g. Proteins were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (3) . No major difference in proteins of membranes of the vancomycin-resistant strain E. faecium 180 and its vancomycin-susceptible derivative were apparent by so- dium dodecyl sulfate-gel electrophoresis when both strains were grown in the absence of vancomycin (Fig. 3) . However, E. faecium 180 showed a novel protein with an apparent molecular weight of 39,000 when membranes from this strain grown in the presence of vancomycin were compared with membranes of the same strain grown in the absence of vancomycin. The relative quantity of this protein appeared to be directly related to the concentration of vancomycin used in the growth medium over a range of 1 to 20 ,ug/ml. The protein was absent or barely detectable in the absence of vancomycin. No major protein band with this apparent molecular weight was detected in the vancomycinsusceptible strain, E. faecium 180-1, even in the presence of 1 ,ug of vancomycin per ml. In E. faecalis 29212R, a vancomycin-resistant transconjugant derived from E. faecalis 29212, a protein of the same apparent molecular weight was observed in membranes of cells grown in the presence of vancomycin. However, this protein was not apparent in this strain grown without vancomycin or in its vancomycinsusceptible parent E. faecalis 29212 (Fig. 3) .
Vancomycin binding by induced and noninduced cells. Binding of vancomycin to whole cells was demonstrated by the method of Best and Durham (1). Cells were grown in CGPY medium (6) with or without vancomycin. Cells were harvested in late logarithmic phase, washed three to five times with distilled water, and suspended in distilled water. Cell suspensions were mixed with vancomycin, and after adsorption, cells were sedimented by centrifugation (10,000
x g for 5 min). The amount of vancomycin bound was determined by measuring the decrease in A280 of the supernatant. No significant difference was found between induced and noninduced cells (Fig. 4) . These data indicate that there is no gross alteration in vancomycin binding or uptake by resistant cultures. However, the sensitivity of our assay was insufficient to detect differences in high-affinity binding sites present in low number.
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